Home › Activist investors › Radoff
Campaign activist. Positions and campaigns from Radoff’s SEC filings. Updated November 20, 2026.
Offer to acquire Radoff’s latest 13D states an offer to acquire the company. It is shown as a bid, not as an activist campaign.
“Item 4 is hereby amended to add the following: On April 13, 2026, the Reporting Persons submitted a non-binding proposal to acquire 100% of the equity of the Issuer at a purchase price of $2.25 per Share in cash, representing a 33% premium to the Issuer's most recent closing price, plus a contingent value right representing the right for stockholders to receive 80% of the net proceeds received from any license, sale…” 13D, Apr 13, 2026
No active campaign by this definition (see How to read this).
| Company | Stake | Source | First disclosed | Last change | Since previous filing | Flags | Stated intent |
|---|---|---|---|---|---|---|---|
| Harte Hanks Inc | 5.7%423,447 shares | Schedule 13D/A, filed Aug 24, 2026 | Dec 6, 2024 | Increased Aug 24, 2026 | ▲ 0.10 pts | Increased | Seeks changes or engagement |
| Barnwell Industries Inc | 11.4%1,680,271 shares | Schedule 13D/A, filed Apr 14, 2026 | Dec 2, 2025 | Increased Mar 31, 2026 | ▼ 1.40 pts | — | Seeks changes or engagement |
| Gse Systems Inc | 7.2%250,000 shares | Schedule 13D, filed Oct 11, 2024 | Oct 11, 2024 | — | — | — | Seeks changes or engagement |
| Newpark Resources Inc | — | Schedule 13D/A, filed Oct 4, 2023stake not read from this filing’s format: see the filing | Jul 25, 2023 | — | — | — | Standard Item 4 language |
| Lifevantage Corp | — | Schedule 13D/A, filed Jul 31, 2024stake not read from this filing’s format: see the filing | Aug 11, 2023 | — | — | — | Seeks changes or engagement |
| Emcore Corp | — | Schedule 13D/A, filed Mar 8, 2024stake not read from this filing’s format: see the filing | Aug 24, 2023 | — | — | — | Seeks changes or engagement |
Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.
Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.
“Item 4 is hereby amended to add the following: On August 14, 2026, the Issuer, Star Equity Holdings, Inc., a Delaware corporation ("Star"), and Merger Sub - R, Inc., a Delaware corporation and a wholly owned subsidiary of Star ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), pursuant to which, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will”
Item 4 in the Schedule 13D/A filed Aug 24, 2026.
Summary of the filing Radoff, a director of Harte Hanks, signed a Support Agreement to vote his shares in favor of the Issuer's merger with Star Equity Holdings, under which shareholders may elect cash of $5.00 per share or Star preferred stock.
Quoted from the filing (item 4): “cash in an amount equal to $5.00 per share (the "Cash Consideration")” Aug 24, 2026
“Mr. Radoff has recommended that Joshua Schecter serve as a director to the Board, and it is expected that Mr. Schecter will join the Board following the Closing. The Purchase Agreement provides that the Issuer will register the resale of the Shares and the Warrant Shares acquired in connection with the Offering. The Issuer is required to prepare and file a registration statement with the Securities and Exchange Commission…”
Item 4 in the Schedule 13D/A filed Apr 14, 2026; this amendment did not restate Item 4, so the text is from the filing of Dec 2, 2025.
“The Reporting Persons purchased the shares on the Reporting Persons’ belief that the Issuer’s proposed take-private merger with affiliates of Pelican Energy Partners Base Zero LP (the “Pelican Merger”) significantly undervalues the Issuer and that the consummation of the Pelican Merger at the current price is not in the best interests of the Issuer or its stockholders. The belated disclosure with incomplete projections…”
“On February 14, 2024 (the “Effective Date”), the Reporting Persons and Sudbury (collectively, the “Stockholder Parties”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with the Issuer pursuant to which, among other things, the Issuer immediately (i) increased the size of its board of directors (the “Board”) by one (1) seat, to a total of eight (8) directors, and (ii) appointed Dayton Judd to the Board, with a term…”
Item 4 in the Schedule 13D/A filed Jul 31, 2024; this amendment did not restate Item 4, so the text is from the filing of Feb 15, 2024.
“hereby amended to add the following: On January 10, 2024, Bradley L. Radoff and the Radoff Foundation (together, the “Radoff Parties”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with the Issuer, pursuant to which the Issuer agreed, among other things, to immediately (i) accept the resignation of Chairman Stephen L. Domenik as a member of the Issuer’s board of directors (the “Board”), (ii) increase the size of the Board by”
Item 4 in the Schedule 13D/A filed Mar 8, 2024; this amendment did not restate Item 4, so the text is from the filing of Jan 11, 2024.
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| Genesco IncBoard seats | Stake reported below 5% | Aug 3, 2026 | Apr 15, 2026 | Proxy contest filed | latest (13) | — |
| Seer, Inc.Board seatsCEO or management change | Bidder: offer to acquire | Apr 13, 2026 | Feb 20, 2026 | Proxy contest filed | latest (40) | — |
| Rocky Mountain Chocolate Factory, Inc.Board seats | Stake reported below 5% | Sep 17, 2025 | Jul 1, 2022 | Proxy contest filed | latest (17) | — |
| Enzo Biochem IncBoard seats | Stake reported below 5% | Aug 22, 2025 | Oct 19, 2021 | Proxy contest filed (preliminary proxy) | latest (4) | — |
| Tetra Technologies Inc | Shareholder meeting held after the soliciting material | Jun 12, 2025 | Mar 24, 2025 | Soliciting material filed | latest (3) | — |
| Atea Pharmaceuticals, Inc.Board seats | Settled (agreement with the company) | Apr 17, 2025 | Mar 4, 2025 | Nominations made | latest (8) | — |
| Alto Ingredients, Inc. | Settled (agreement with the company) | Mar 18, 2025 | Feb 24, 2025 | — | latest (4) | — |
| Lifevantage CorpBoard seats | Settled (agreement with the company) | Feb 15, 2024 | Aug 11, 2023 | Proxy contest filed | latest (14) | how managers voted |
| Emcore CorpBoard seats | Settled (agreement with the company) | Jan 11, 2024 | Aug 24, 2023 | Nominations made | latest (4) | — |
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| INVE Technologies, Inc. | 4.9% | Schedule 13D/A, filed Nov 5, 2026 | Reported below 5% in a 13D/A | Nov 5, 2026 |
| Genesco Inc | 4.8% | Schedule 13D/A, filed Aug 3, 2026 | Reported below 5% in a 13D/A | Aug 3, 2026 |
| Seer, Inc. | 4.6% | Schedule 13D/A, filed Apr 13, 2026 | Reported below 5% in a 13D/A | Apr 13, 2026 |
| Rocky Mountain Chocolate Factory, Inc. | 4.6% | Schedule 13D/A, filed Sep 17, 2025 | Reported below 5% in a 13D/A | Sep 17, 2025 |
| Enzo Biochem Inc | 0.0% | Schedule 13D/A, filed Aug 22, 2025 | Exited | Aug 22, 2025 |
| Presidio Property Trust, Inc. | 0.3% | Schedule 13D/A, filed May 21, 2025 | Reported below 5% in a 13D/A | May 21, 2025 |
| Atea Pharmaceuticals, Inc. | 4.0% | Schedule 13D/A, filed Apr 17, 2025 | Reported below 5% in a 13D/A | Apr 17, 2025 |
| Alto Ingredients, Inc. | 4.7% | Schedule 13D/A, filed Mar 18, 2025 | Reported below 5% in a 13D/A | Mar 18, 2025 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
Contested director elections at which Radoff had nominees on the ballot, from the managers’ N-PX vote reports and the company’s Form 8-K (Item 5.07) results. A manager “backed” a side when most of its funds’ votes on that side’s nominees were FOR; with a universal proxy card a fund can vote for nominees of both sides, so the counts are shown too.
| Manager | Backed the activist | Lifevantage Corp 2023 |
|---|---|---|
| Vanguard | 0 of 1 (0%) | Company |
| Fidelity | 0 of 1 (0%) | Company |
| EA Series Trust | 1 of 1 (100%) | Activist |
| BlackRock | 0 of 1 (0%) | Company |
| Charles Schwab | 0 of 1 (0%) | Company |
| Equitable | 0 of 1 (0%) | Company |
| Allianz | 0 of 1 (0%) | Split |
| American Century | 0 of 1 (0%) | Split |
| BRIDGEWAY FUNDS INC | 0 of 1 (0%) | Split |
| Dimensional | 0 of 1 (0%) | Split |
| Jackson National | 0 of 1 (0%) | Split |
| Lincoln Financial | 0 of 1 (0%) | Split |
| RBC FUNDS TRUST | 0 of 1 (0%) | Split |
| T. Rowe Price | 0 of 1 (0%) | Split |
| Victory Capital | 0 of 1 (0%) | Split |
— = no N-PX votes on the contested director elections found for that manager.
Result: Form 8-K, Item 5.07. Activist’s nominees: Mr. Bradley L. Radoff (not elected (8-k tally)). Company’s nominees: Mr. Michael A. Beindorff (elected (8-k tally)); Ms. Erin Brockovich (elected (8-k tally)); Mr. Steven R. Fife (elected (8-k tally)); Mr. Raymond B. Greer (elected (8-k tally)); Ms. Cynthia Latham (elected (8-k tally)); Mr. Darwin K. Lewis (elected (8-k tally)); Mr. Garry Mauro (elected (8-k tally)); Mr. Dayton Judd (not elected (8-k tally)); Mr. Michael Lohner (not elected (8-k tally)).
| Manager | Stance | FOR the activist’s nominees | Avg. shares FOR each activist nominee | FOR the company’s nominees |
|---|---|---|---|---|
| Vanguard | Backed the company's nominees | 0 of 3 fund votes | 0 | 21 of 21 fund votes |
| Fidelity | Backed the company's nominees | 0 of 4 fund votes | 0 | 28 of 28 fund votes |
| EA Series Trust | Backed the activist's nominees | 1 of 1 fund votes | 61,188 | 0 of 0 fund votes |
| BlackRock | Backed the company's nominees | 0 of 1 fund votes | 0 | 7 of 7 fund votes |
| Charles Schwab | Backed the company's nominees | 0 of 1 fund votes | 0 | 6 of 7 fund votes |
| Equitable | Backed the company's nominees | 0 of 1 fund votes | 0 | 7 of 7 fund votes |
| Allianz | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| American Century | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| BRIDGEWAY FUNDS INC | Split | 0 of 2 fund votes | 0 | 0 of 0 fund votes |
| Dimensional | Split | 0 of 15 fund votes | 0 | 0 of 0 fund votes |
| Jackson National | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| Lincoln Financial | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| RBC FUNDS TRUST | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| T. Rowe Price | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
| Victory Capital | Split | 0 of 1 fund votes | 0 | 0 of 0 fund votes |
Source: N-PX reports filed by 15 managers for the meeting of Nov 6, 2023; a nominee’s side is read from how most filers labelled the ballot item (two or more filers, 70% agreeing).
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| Genesco Inc | Withdrawn | filing | Jun 10, 2026 | Apr 15, 2026 |
| Seer, Inc. | Stake reported below 5% | filing | Apr 13, 2026 | Feb 20, 2026 |
| Rocky Mountain Chocolate Factory, Inc. | Stake reported below 5% | filing | Sep 17, 2025 | Jul 1, 2022 |
| Enzo Biochem Inc | Stake reported below 5% | filing | Aug 22, 2025 | Oct 19, 2021 |
| Tetra Technologies Inc | No outcome in the filings read | — | Jun 12, 2025 | Mar 24, 2025 |
| Atea Pharmaceuticals, Inc. | Settlement | agreement with the company | Apr 17, 2025 | Mar 4, 2025 |
| Alto Ingredients, Inc. | Settlement | agreement with the company | Mar 18, 2025 | Feb 24, 2025 |
| Lifevantage Corp | Settlement | agreement with the company | Feb 15, 2024 | Aug 11, 2023 |
| Emcore Corp | Settlement | agreement with the company | Jan 11, 2024 | Aug 24, 2023 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 2 of 14 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
| Company | First 13D | To latest close | SPY same dates | 6 months after | 12 months after |
|---|---|---|---|---|---|
| Seer, Inc. SEER | Feb 20, 2026 | -27.3%Feb 20, 2026 – Nov 18, 2026 | +5.9% | +2.5%SPY +11.1% | not yet / no price |
| Barnwell Industries Inc BRN | Dec 2, 2025 | -26.3%Dec 2, 2025 – Nov 18, 2026 | +7.1% | -3.5%SPY +10.7% | not yet / no price |
Prices: daily closes (Nasdaq), as stored by the site.
Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.
“Item 4 is hereby amended to add the following: On April 16, 2025, the Radoff/JEC Group entered into a letter agreement (the "Agreement") with the Issuer pursuant to which, among other things, the Issuer agreed to appoint Howard H. Berman, Ph.D. to the Board, effective immediately following the Issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), as a Class III director with a term expiring at the…” 13D Item 4, Apr 17, 2025
“Pursuant to the Cooperation Agreement, Mr. Radoff withdrew his nomination of director candidates for election to the Board at the 2024 Annual Meeting and the Radoff Parties are subject to certain customary standstill restrictions from the date of the Cooperation Agreement until the earlier of (x) 30 days prior to the deadline for submissions of shareholder nominations for the Issuer’s 2025 annual meeting of sharehold…” 13D Item 4, Jan 11, 2024
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Radoff’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| Pzena Investment Management LLC | Schedule 13G | Jan 30, 2026 | 11.5% |
| Fund 1 Investments, LLC | Schedule 13G | May 15, 2026 | 3.9% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Barnwell Industries, Inc. Employees' Pension Plan Trust | Schedule 13D | Jul 3, 2025 | 5.2% |
| JCP Investment | Schedule 13D | Apr 17, 2026 | 5.1% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Harbert Discovery | Schedule 13D | Jun 25, 2025 | 9.9% |
| Battery Ventures XIV, L.P. | Schedule 13D | Jun 30, 2025 | 21.8% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Pictet Asset Management SA | Schedule 13D | Apr 15, 2025 | 5.3% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| BML Investment Partners, L.P. | Schedule 13D | Dec 16, 2024 | 8.5% |
| EcoR1 Capital, LLC | Schedule 13G | Feb 14, 2025 | 4.0% |
| BlackRock, Inc. | Schedule 13G | Apr 23, 2025 | 7.1% |
| Jean-Pierre Sommadossi | Schedule 13G | May 14, 2025 | 10.1% |
| FMR LLC | Schedule 13G | Aug 6, 2025 | 6.7% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| DOMO Capital Management, LLC | Schedule 13G | Jan 7, 2025 | 7.1% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Gary S. Rosenbach | Schedule 13D | May 30, 2025 | 28.8% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Loudermilk Kyle Justin | Schedule 13D | May 6, 2024 | 5.7% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Global Value Investment Corp. | Schedule 13D | Jul 21, 2023 | 21.1% |